 |
|
Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
Sunghoon Park, Joo-Hee Kim, Yong Il Hwang, Ki-Suck Jung, Young Sook Jang, Seung Hun Jang
Tuberc Respir Dis. 2014;76(3):114-119. Published online 2014 Mar 29 DOI: https://doi.org/10.4046/trd.2014.76.3.114
|
|
Citations to this article as recorded by
 c-Jun N-terminal Kinase (JNK), p38, and Caspases: Promising Therapeutic
Targets for the Regulation of Apoptosis in Cancer Cells by Phytochemicals
Manish Kumar, Satwinderjeet Kaur, Sandeep Kaur
Current Cancer Therapy Reviews.2024; 20(2): 200. CrossRef Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects
Mei-Lin Chen, Chih-Jen Lai, Yi-Nan Lin, Chien-Ming Huang, Yu-Hsin Lin
Journal of Materials Chemistry B.2020; 8(45): 10416. CrossRef Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells – The involvement of carbonyl reductase 1 inhibition
Kamil Piska, Paulina Koczurkiewicz, Dawid Wnuk, Elżbieta Karnas, Adam Bucki, Katarzyna Wójcik-Pszczoła, Marek Jamrozik, Marta Michalik, Marcin Kołaczkowski, Elżbieta Pękala
Chemico-Biological Interactions.2019; 300: 40. CrossRef Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
Fwu-Long Mi, Li-Fang Wang, Pei-Yi Chu, Shin-Lei Peng, Chun-Lung Feng, Ying-Jing Lai, Jia-Ni Li, Yu-Hsin Lin
ACS Biomaterials Science & Engineering.2018; 4(8): 2847. CrossRef Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non‐small cells lung cancer to chemotherapy
Ali Flores‐Pérez, Laurence A. Marchat, Lidia López Sánchez, Diana Romero‐Zamora, Elena Arechaga‐Ocampo, Nayeli Ramírez‐Torres, José Díaz Chávez, Ángeles Carlos‐Reyes, Horacio Astudillo‐de la Vega, Erika Ruiz‐García, Abrahan González‐Pérez, César López‐Cam
PROTEOMICS – Clinical Applications.2016; 10(2): 172. CrossRef Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel
JUAN SEBASTIAN YAKISICH, NEELAM AZAD, RAJKUMAR VENKATADRI, YOGESH KULKARNI, CLAYTON WRIGHT, VIVEK KAUSHIK, GEORGE A. O'DOHERTY, ANAND KRISHNAN V. IYER
Oncology Reports.2016; 35(2): 878. CrossRef South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and Radiotherapy
N. Prasad, Ganesan Muthusamy, Mohana Shanmugam, Suresh Ambudkar
Cancers.2016; 8(3): 32. CrossRef
|